Ledger.Open graph →
SEC Form D · filed March 3, 2020

Aspargo Laboratories, Inc

Offering
$8.5M
Sold
$235K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ENGLEWOOD CLIFFS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Michael Rice · Englewood, NJDirectorMichael Demurjian · Red Bank, NJExec · DirectorFred Biehl · Roseland, NJDirectorDean Stathakis · Huntington Beach, CADirectorGerald Birch · Huntington Beach, CAExec · DirectorTodd Cash · Gilbert, AZDirectorKwame Ennin · Dallas, TXDirectorChip Zahn · Dallas, TXDirectorJohn T. Mitchell · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗